Literature DB >> 19296888

Counterpoint: Hydroxyapatite crystal deposition is not intimately involved in the pathogenesis and progression of human osteoarthritis.

Kenneth P H Pritzker1.   

Abstract

The association of hydroxyapatite deposition with osteoarthritis pathogenesis and progression remains controversial, even after decades of study. Hydroxyapatite crystals are found in osteoarthritis in advanced disease only. Even then, hydroxyapatite crystals are found in such small amounts that special analytical techniques are required to detect the crystals. Further, the osteoarthritic joint fluid appears noninflammatory, suggesting that such hydroxyapatite crystals have very small effect on the pathologic process. Formal histopathologic evidence is scant, but hydroxyapatite crystal deposition within osteoarthritic synovium or cartilage is a rare event. Hydroxyapatite crystals may be present at end-stage osteoarthritis, but in insufficient amounts to contribute significantly to osteoarthritis pathogenesis or progression. This review critically examines the evidence from osteoarthritic synovial fluids, imaging, and histopathology to determine whether the well-characterized in vitro cellular reactions to hydroxyapatite apply to the pathogenesis of human osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296888     DOI: 10.1007/s11926-009-0021-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  43 in total

1.  Crystal deposition in joints: prevalence and relevance for arthritis.

Authors:  Kenneth P H Pritzker
Journal:  J Rheumatol       Date:  2008-06       Impact factor: 4.666

2.  Chondrocalcinosis: a secondary finding in osteoarthritis of the knee.

Authors:  J Hernborg; B Linden; B E Nilsson
Journal:  Geriatrics       Date:  1977-09

3.  The high prevalence of pathologic calcium crystals in pre-operative knees.

Authors:  Beth A Derfus; Jason B Kurian; Jeffrey J Butler; Laureen J Daft; Guillermo F Carrera; Lawrence M Ryan; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

4.  Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha.

Authors:  Paul M Reuben; Michele A Brogley; Yubo Sun; Herman S Cheung
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

Review 5.  Basic calcium phosphate crystals as a unique therapeutic target in osteoarthritis.

Authors:  Linda C Whelan; Maria P Morgan; Geraldine M McCarthy
Journal:  Front Biosci       Date:  2005-01-01

6.  Basic calcium phosphate crystals activate p44/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts.

Authors:  Paul M Reuben; Yubo Sun; Herman S Cheung
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

7.  Osteoarthritic cartilage contains increased calcium, magnesium and phosphorus.

Authors:  K P Pritzker; J M Châteauvert; M D Grynpas
Journal:  J Rheumatol       Date:  1987-08       Impact factor: 4.666

8.  Association between crystals and cartilage degeneration in the ankle.

Authors:  Carol Muehleman; Jun Li; Thomas Aigner; Lev Rappoport; Eric Mattson; Carol Hirschmugl; Koichi Masuda; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2008-04-15       Impact factor: 4.666

9.  Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1 beta.

Authors:  G J Carroll; R A Stuart; J A Armstrong; P D Breidahl; B A Laing
Journal:  J Rheumatol       Date:  1991-06       Impact factor: 4.666

10.  Alizarin red S staining as a screening test to detect calcium compounds in synovial fluid.

Authors:  H Paul; A J Reginato; H R Schumacher
Journal:  Arthritis Rheum       Date:  1983-02
View more
  9 in total

Review 1.  The role of uric acid and other crystals in osteoarthritis.

Authors:  Johannes Nowatzky; Rennie Howard; Michael H Pillinger; Svetlana Krasnokutsky
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

2.  NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy.

Authors:  Chengcheng Jin; Patrick Frayssinet; Richard Pelker; Diane Cwirka; Bo Hu; Agnès Vignery; Stephanie C Eisenbarth; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-19       Impact factor: 11.205

Review 3.  Rapidly Progressive Osteoarthritis: a Review of the Clinical and Radiologic Presentation.

Authors:  Donald J Flemming; Cristy N Gustas-French
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 4.  Matrix vesicles from chondrocytes and osteoblasts: Their biogenesis, properties, functions and biomimetic models.

Authors:  Massimo Bottini; Saida Mebarek; Karen L Anderson; Agnieszka Strzelecka-Kiliszek; Lukasz Bozycki; Ana Maria Sper Simão; Maytê Bolean; Pietro Ciancaglini; Joanna Bandorowicz Pikula; Slawomir Pikula; David Magne; Niels Volkmann; Dorit Hanein; José Luis Millán; Rene Buchet
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-11-03       Impact factor: 3.770

5.  Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilage.

Authors:  Christelle Nguyen; Dominique Bazin; Michel Daudon; Aurore Chatron-Colliet; Didier Hannouche; Arnaud Bianchi; Dominique Côme; Alexander So; Nathalie Busso; Nathalie Busso; Frédéric Lioté; Hang-Korng Ea
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

6.  The Therapeutic Potential of Exogenous Adenosine Triphosphate (ATP) for Cartilage Tissue Engineering.

Authors:  Jenna Usprech; Gavin Chu; Renata Giardini-Rosa; Kathleen Martin; Stephen D Waldman
Journal:  Cartilage       Date:  2012-10       Impact factor: 4.634

7.  Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography.

Authors:  Hidenori Tanikawa; Ryo Ogawa; Kazunari Okuma; Kengo Harato; Yasuo Niki; Shu Kobayashi; Takeo Nagura
Journal:  J Orthop Surg Res       Date:  2018-04-05       Impact factor: 2.359

Review 8.  The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Authors:  Alberto Altomare; Addolorata Corrado; Nicola Maruotti; Daniela Cici; Francesco Paolo Cantatore
Journal:  Mol Biol Rep       Date:  2021-06-01       Impact factor: 2.316

9.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.